Atlas Trials

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

Clinical trial NCT02662894 · WITHDRAWN

Trial details

NCT number
NCT02662894
Sponsor
EMS
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
HypertensionDyslipidemia
Start date
2019-10-01
Primary completion
2020-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.